{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:26:13Z","timestamp":1789709173420,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.antiviral.2010.04.007","type":"journal-article","created":{"date-parts":[[2010,4,24]],"date-time":"2010-04-24T08:25:36Z","timestamp":1272097536000},"page":"78-80","source":"Crossref","is-referenced-by-count":37,"title":["A novel nucleoside analog, 1-\u03b2-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro"],"prefix":"10.1016","volume":"87","author":[{"given":"Michael","family":"McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidath C.","family":"Kumarapperuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Jeselnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Arterburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2010.04.007_bib1","doi-asserted-by":"crossref","first-page":"35638","DOI":"10.1074\/jbc.M400460200","article-title":"A structural basis for the inhibition of the NS5 dengue virus mRNA 2\u2032-O-methyltransferase domain by ribavirin 5\u2032-triphosphate","volume":"279","author":"Benarroch","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2010.04.007_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.510260231","article-title":"Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial","volume":"26","author":"Bodenheimer","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2010.04.007_bib3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2006.08.005","article-title":"Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses","volume":"73","author":"Buckwold","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.04.007_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2008.02.003","article-title":"Synthesis of 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus","volume":"79","author":"Chung","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.04.007_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00705-005-0626-6","article-title":"A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission","volume":"151","author":"Cook","year":"2006","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2010.04.007_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(02)00185-7","article-title":"Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses","volume":"58","author":"Crance","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.04.007_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2005.04.002","article-title":"Error-prone replication of West Nile virus caused by ribavirin","volume":"67","author":"Day","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.04.007_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.drudis.2008.04.001","article-title":"Present perspectives on flaviviral chemotherapy","volume":"13","author":"Ghosh","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2010.04.007_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2010.04.007_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0042-6822(03)00197-1","article-title":"A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4","volume":"312","author":"Hanley","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2010.04.007_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.26.4.476","article-title":"Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses","volume":"26","author":"Huggins","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.04.007_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2006.08.008","article-title":"Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model","volume":"73","author":"Julander","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.04.007_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.24.3.353","article-title":"Broad-spectrum antiviral activity of 2-beta-d-ribofuranosylselenazole-4-carboxamide, a new antiviral agent","volume":"24","author":"Kirsi","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.04.007_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.ento.53.103106.093258","article-title":"A global perspective on the epidemiology of West Nile virus","volume":"53","author":"Kramer","year":"2008","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.antiviral.2010.04.007_bib15","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.bmcl.2007.03.018","article-title":"Structural effects on the phosphorylation of 3-substituted 1-beta-d-ribofuranosyl-1,2,4-triazoles by human adenosine kinase","volume":"17","author":"Kumarapperuma","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2010.04.007_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.micro.62.081307.163005","article-title":"Global spread and persistence of dengue","volume":"62","author":"Kyle","year":"2008","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2010.04.007_bib17","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.04.007_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1128\/CMR.13.1.67-82.2000","article-title":"Perspectives for the treatment of infections with Flaviviridae","volume":"13","author":"Leyssen","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2010.04.007_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.04.007_bib20","article-title":"To what extent has climate change contributed to the recent epidemiology of tick-borne diseases?","author":"Randolph","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.antiviral.2010.04.007_bib21","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2174\/092986706778773059","article-title":"Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research","volume":"13","author":"Russmann","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2010.04.007_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","article-title":"Molecular targets for flavivirus drug discovery","volume":"81","author":"Sampath","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.04.007_bib23","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2741\/2769","article-title":"Nucleic acid-based inhibition of flavivirus infections","volume":"13","author":"Stein","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.antiviral.2010.04.007_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AAC.00790-06","article-title":"Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5\u2032-triphosphate, not with inhibition of IMP dehydrogenase","volume":"51","author":"Sun","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.04.007_bib25","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1099\/vir.0.81655-0","article-title":"Inhibition of dengue virus replication by mycophenolic acid and ribavirin","volume":"87","author":"Takhampunya","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2010.04.007_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/095632020301400102","article-title":"Ribavirin derivatives with a hexitol moiety: synthesis and antiviral evaluation","volume":"14","author":"Van Aerschot","year":"2003","journal-title":"Antivir. Chem. Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210005772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210005772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T17:28:07Z","timestamp":1544549287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354210005772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0166354210005772"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2010.04.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}